NCT01078038

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III: Sirolimus vs. Everolimus-eluting Stent

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 451 (actual)
• Sponsor: Seung-Jung Park · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This randomized study is a multi-center, randomized, study to compare the efficacy of sirolimus versus everolimus-eluting stent implantation for long coronary lesions.

Detailed description

Following angiography, patients with significant diameter stenosis \>50% and lesion length (\> 25mm) requiring single or multiple long-stent placement (total stent length \>28mm) by visual estimation and eligible for LONG-DES III trial inclusion and exclusion criteria will be randomized 1:1 to a) sirolimus-eluting and b) everolimus-eluting stent by the stratified randomization method.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Cypher	Sirolimus-eluting stent implantation
DEVICE	Xience V	Everolimus-eluting Stent implantation

Timeline

• Start date: 2008-06-01
• Primary completion: 2010-06-01
• Completion: 2010-08-01
• First posted: 2010-03-02
• Last updated: 2012-08-08

Locations

20 sites across 1 country: South Korea